In light of the urgent need for new drugs in HNSCC treatment, our study utilized CTRP and GDSC data from GSCA to explore SERPINE1 and anticancer drugs, aiming to identify potential therapeutic options. This evidence concerns the gene SERPINE1 and head and neck squamous cell carcinoma.